NCT04120753View on ClinicalTrials.gov

Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab

PHASE4CompletedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

August 26, 2019

Primary Completion Date

July 6, 2021

Study Completion Date

July 6, 2021

Conditions
HypertensionDyslipidemias
Interventions
DRUG

OLOMAX 20/5/5mg

Tablets, Oral, QD

DRUG

OLOMAX 20/5/10mg

Tablets, Oral, QD

DRUG

Olmesartan 20 mg/Amlodipine 5 mg

Tablets, Oral, QD

Trial Locations (1)

Unknown

Daewoong pharmatceutical, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY